Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unmet needs in the scientific approach to older patients with lymphoma.
Bron D, Aurer I, André MPE, Bonnet C, Caballero D, Falandry C, Kimby E, Soubeyran P, Zucca E, Bosly A, Coiffier B; European Lymphoma Institute (ELI) Group and the EHA SWG “Aging and Hematology”. Bron D, et al. Among authors: falandry c. Haematologica. 2017 Jun;102(6):972-975. doi: 10.3324/haematol.2017.167619. Haematologica. 2017. PMID: 28566341 Free PMC article. Review. No abstract available.
Senotherapy, cancer, and aging.
Balducci L, Falandry C, Silvio Monfardini. Balducci L, et al. Among authors: falandry c. J Geriatr Oncol. 2024 May;15(4):101671. doi: 10.1016/j.jgo.2023.101671. Epub 2023 Nov 17. J Geriatr Oncol. 2024. PMID: 37977898 Review.
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Tubiana-Mathieu N, Cany L, Catala S, Khayat D, Pauporté I, Kramar A; PHARE trial investigators. Pivot X, et al. Lancet Oncol. 2013 Jul;14(8):741-8. doi: 10.1016/S1470-2045(13)70225-0. Epub 2013 Jun 11. Lancet Oncol. 2013. PMID: 23764181 Clinical Trial.
Tailoring a specific medical leadership development program for faculty members: the Lyon-Ottawa experience.
Falandry C, Bacchetta J, Doret-Dion M, Ferraro-Peyret C, Confavreux CB, Douplat M, Feugier P, Friggeri A, Bolze PA, Dargaud Y, Messager A, Wallon M, Geffroy L, Matillon Y, Bradwejn J. Falandry C, et al. Med Educ Online. 2024 Dec 31;29(1):2308955. doi: 10.1080/10872981.2024.2308955. Epub 2024 Jan 30. Med Educ Online. 2024. PMID: 38290044 Free PMC article.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Pivot X, Romieu G, Debled M, Pierga JY, Kerbrat P, Bachelot T, Lortholary A, Espié M, Fumoleau P, Serin D, Jacquin JP, Jouannaud C, Rios M, Abadie-Lacourtoisie S, Venat-Bouvet L, Cany L, Catala S, Khayat D, Gambotti L, Pauporté I, Faure-Mercier C, Paget-Bailly S, Henriques J, Grouin JM; PHARE trial investigators. Pivot X, et al. Lancet. 2019 Jun 29;393(10191):2591-2598. doi: 10.1016/S0140-6736(19)30653-1. Epub 2019 Jun 6. Lancet. 2019. PMID: 31178155 Clinical Trial.
Enhancing collaboration between geriatricians, oncologists, and pharmacists to optimize medication therapy in older adults with cancer: A position paper from SOFOG-SFPO.
Herledan C, Toulemonde A, Clairet AL, Boulin M, Falandry C, Decker L, Rioufol C, Bayle A, Bertrand N. Herledan C, et al. Among authors: falandry c. Crit Rev Oncol Hematol. 2023 Oct;190:104117. doi: 10.1016/j.critrevonc.2023.104117. Epub 2023 Sep 1. Crit Rev Oncol Hematol. 2023. PMID: 37660933 Review.
Taking care of older patients with cancer in the context of COVID-19 pandemic.
Mourey L, Falandry C, de Decker L, Boulahssass R, Carola E, Bengrine Lefevre L, Cudennec T, Brain E, Paillaud E, Soubeyran P. Mourey L, et al. Among authors: falandry c. Lancet Oncol. 2020 May;21(5):e236. doi: 10.1016/S1470-2045(20)30229-1. Epub 2020 Apr 14. Lancet Oncol. 2020. PMID: 32302533 Free PMC article. No abstract available.
109 results